New Immunotherapy for Pediatric Brain Cancer Targets Mutated Protein – Pharmaceutical Technology Magazine
|
New Immunotherapy for Pediatric Brain Cancer Targets Mutated Protein
Pharmaceutical Technology Magazine According to research lead by the University of California San Francisco (UCSF), children with a deadly form of brain cancer might benefit from a new treatment that aims to direct an immune response against a mutated protein found exclusively on cancer … |
